| __timestamp | Corcept Therapeutics Incorporated | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 34916000 | 1244910 |
| Thursday, January 1, 2015 | 36949000 | 5029636 |
| Friday, January 1, 2016 | 45240000 | 4846776 |
| Sunday, January 1, 2017 | 62416000 | 5329003 |
| Monday, January 1, 2018 | 81289000 | 7121000 |
| Tuesday, January 1, 2019 | 100359000 | 9128000 |
| Wednesday, January 1, 2020 | 105326000 | 10731000 |
| Friday, January 1, 2021 | 122356000 | 10701000 |
| Saturday, January 1, 2022 | 152848000 | 16121000 |
| Sunday, January 1, 2023 | 184259000 | 37021000 |
Infusing magic into the data realm
In the competitive landscape of biotechnology, effective cost management is crucial. Over the past decade, Corcept Therapeutics Incorporated and Viking Therapeutics, Inc. have demonstrated contrasting strategies in managing their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Corcept Therapeutics saw a staggering 428% increase in SG&A expenses, reflecting their aggressive expansion and investment in operational capabilities. In contrast, Viking Therapeutics, while also experiencing growth, maintained a more conservative approach with a 287% rise over the same period. This divergence highlights the strategic choices companies make in balancing growth and cost efficiency. As of 2023, Corcept's SG&A expenses are nearly five times that of Viking's, underscoring their differing scales and market strategies. Understanding these trends provides valuable insights into the financial health and strategic priorities of these biotech firms.
Who Optimizes SG&A Costs Better? Merck & Co., Inc. or Viking Therapeutics, Inc.
AstraZeneca PLC vs Viking Therapeutics, Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Amgen Inc. vs Viking Therapeutics, Inc.
Comparing SG&A Expenses: Takeda Pharmaceutical Company Limited vs Viking Therapeutics, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Neurocrine Biosciences, Inc. and Viking Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Incyte Corporation and Corcept Therapeutics Incorporated
Dr. Reddy's Laboratories Limited and Corcept Therapeutics Incorporated: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Catalent, Inc. vs Viking Therapeutics, Inc. Trends and Insights
Corcept Therapeutics Incorporated and Perrigo Company plc: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Corcept Therapeutics Incorporated vs MorphoSys AG Trends and Insights
SG&A Efficiency Analysis: Comparing Corcept Therapeutics Incorporated and Travere Therapeutics, Inc.
Viking Therapeutics, Inc. and Perrigo Company plc: SG&A Spending Patterns Compared